As of Oct 18
| -1.10 / -3.92%|
The 1 analysts offering 12-month price forecasts for Odonate Therapeutics Inc have a median target of 45.00, with a high estimate of 45.00 and a low estimate of 45.00. The median estimate represents a +66.98% increase from the last price of 26.95.
The current consensus among 2 polled investment analysts is to Buy stock in Odonate Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.